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The genome of hepatitis A virus (HAV) isolated from spontaneously infected African vervet monkey (Cercopithecus ae- 
rhiops) has been cloned and partially sequenced. Comparison of genome fragments (1248 and 162 bp) from the 3D (RNA 
polymerase) region with the corresponding parts of human HAV genomes revealed a high degree of heterogeneity: there 
were altogether 257 nucleotide changes leading to 44 substitutions in predicted amino acid sequence, i.e. 89% amino acid 
identity. This divergence is considered to be significantly greater than genomic variations usually found among human 
HAV strains, where amino acid identity in the 3D region is over 98%. 
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1. INTRODUCTION 
In recent years several hepatitis A virus (HAV) 
strains originally isolated from humans have been 
cloned and completely or partially sequenced [l-7 1. 
Sequence analysis has shown a high degree of 
genomic homology among strains of diverse 
geographic origin as well as between the ‘wild’ and 
cell-culture-adapted variants [6-S]. The HAV 
strains so far compared appeared to have identity 
in greater than 90% of nucleotides and almost 98% 
of predicted amino acids [9]. Antigenic comparison 
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The nucleotide sequences presented here have been submitted to 
the EMBL/GenBank database under the accession no. YO7509 
has also demonstrated a close relatedness of all 
known HAV strains (review [lo]). 
It has become evident that spontaneous hepatitis 
A infection occurs in certain species of non-human 
primates including New [l l] and Old 1121 World 
monkeys. The virus isolated from infected animals 
shared the main antigenic characteristics of human 
HAV, but could be differentiated with some mono- 
clonal antibodies [ 131. 
We report here a first attempt at cloning the 
genome of HAV isolated from a spontaneously in- 
fected African vervet monkey. Genome fragments 
available for sequence analysis corresponded to the 
cDNA part coding for RNA polymerase (3D pro- 
tein). 
2. MATERIALS AND METHODS 
2.1. Virus 
Spontaneously infected African vervet monkey (Cercopithe- 
cusuethiops) was killed at the peak of the disease (serum alanine 
aminotransferase levation). The presence of HAV particles hi 
the liver has been demonstrated by immuno-electron micro- 
scopy, immunofluorescence, and enzyme immunoassay. A 15% 
(w/v) suspension of liver tissue (total, 750 g) was prepared and 
Published by Elsevier Science Publishers B. K (Biomedical Division) 
00145793/89/$3.50 0 1989 Federation of European Biochemical Societies 425 
Volume 241, number 2 FEBS LETTERS April 1989 
treated with liquid Nz and freon-l 13 followed by low-speed cen- 
trifugation. Virus liberated into the aqueous phase was pelleted 
on a CsCl cushion (1.40 g/cm’) and further purified by con- 
secutive isopycnic and rate-zonal centrifugation in CsCl and 
sucrose gradients, respectively. Finally, virus was concentrated 
by pelleting on the bottom of centrifuge tubes and resuspending 
in miminal volume of 0.1 M PBS. During the entire procedure 
the virus was monitored by enzyme immunoassay and immuno- 
electron microscopy. 
RNA was extracted from virus particles using hot phenol and 
chloroform after pre-incubation with proteinase K (500 fig/ml) 
in the presence of SDS (0.5%). The amount of viral RNA in the 
extract was calculated to be 10 ng. 
2.2. Cloning 
Viral RNA was reverse-transcribed into single-stranded 
cDNA using oligo(dT)rz-1s as primer. The second strand was 
obtained by E. coli DNA polymerase I directed synthesis in the 
presence of RNase H, yielding approx. 0.2 cg double-stranded 
cDNA. EcoRI linkers were tailed to this cDNA and then cleaved 
with EcoRI. 
To remove excess linkers cDNA was mixed with tRNA at final 
concentration of 0.5 mg/ml and twice precipitated with an 
equal volume of isopropanol followed by 1 h incubation and 
centrifugation. The cDNA (2 ng) was inserted into hgt 10 phage 
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DNA cleaved with EcoRI (overnight at +4”C). The con- 
catemers obtained were packaged in vitro into h phage proteins, 
reaching an efficiency of packaging of 2-5 x lo7 pfu/pg inser- 
tion. The selective BNN 102 strain of E. coli [14] was used for 
plating with vector background no greater than 5%. To generate 
the clone library 2 x lo5 individual clones were plated at a densi- 
ty of 5 x 104 colonies per lOO-mm plate. Amplification was 
achieved by elution of phages into SM medium for 16 h. The 
amplified library available for screening has a titre of 
10” pfu/ml. Phage recombinants containing the HAV se- 
quences were identified via DNA-DNA colony-blot hybridiza- 
tion with nick-translated 3ZP-labelled DNAs complementary to 
three different parts of the human HAV genome from a plasmid 
library described elsewhere [15]. For determination of the 
primary structure of inserts they were recloned into the EcoRI 
site of pUC19 plasmid 
2.3. Sequencing and sequence analysis 
Nucleotide sequences of the inserts were determined using the 
procedure of Maxam and Gilbert [16]. Amino acid sequences of 
picornavirus RNA polymerases were aligned by OPTAL pro- 
gramme [17] run on an ES-1060 computer. Putative enzyme ac- 
tive sites for HAV RNA polymerase were identified from align- 
ment of amino acid sequences of HAV with those of other picor- 
naviruses. 
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Fig. 1. Nucleotide sequences of cDNA fragments from the 3D (RNA polymerase) region. Comparison of simian (siHAV) and human 
(HASIS) HAVs (italicized letters denote changes resulting in differences in predicted amino acid sequence). 
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3. RESULTS 
Two cDNA fragments identified in phage recom- 
binants contained respectively 1248 and 162 bp 
representing the region of the genome encoding 3D 
protein, i.e. RNA polymerase. According to the 
numbering system suggested by Najarian et al. [4] 
for the human HAV genome, one fragment is posi- 
tioned between nucleotides 5951 and 7198 in- 
elusive, the other from nucleotide 7314 onwards. 
The latter carries the sequence corresponding to 
144 nucleotides at the 3 ‘-end, including the non- 
translated region and part of the poly(A) tract. 
Both fragments cover almost 95% of the 3D 
region. 
The nucleotide composition of these fragments 
differs from the corresponding parts of the human 
HAV genome, HAS-15 strain [ 181, by altogether 
257 scattered changes (81.5% identity) which result 
in 44 differences in the predicted amino acid se- 
quence (fig. 1). 
Computer-aided comparison of the predicted 
amino acid sequences with those of other picorna- 
viruses (fig.2) revealed that, despite the high degree 
of genomic heterogeneity in this region, the sub- 
stitutions found in simian HAV RNA apparently 
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GCDPDLEWSKIFVLME--EK-LEAE~YTGY~ASLSPAWEEAL--KMVLEKIGFGDRVD-- 
GCDPDCFWSKIPVMLD--GH-CIAFDYSGYDASLSPVWFACL--KMLCEKCGYTHKETN- 
GCDPDVFWSVIPCLMD--GH-LMAFDYSNFDASLSPVWFVCL--EKVLTKLGFAGSS--- 
GCDPEVFWSKIPAMLD--DKCIMAFDYTNYDGSIHPIWFEAL--KGVLVDLSFNPT---- 
GCDPDVHWTAFGVAMQGF-ERVYDVDYSNFDSTHSVAMFRLLAEEFFTPENGFDPLTRE- 
GCNPDVDWQRFGTHFAQY-RNVWDVDYSAFDANHCSDAMNIMFEEVFRTDFGFHPNAEW- 
GIDPDRQWDELFKTMIRFGDVGLDLDFSAFDASLSPFMIREAG-RIMSELSGTPSHFGTA 
GIDPDRHWDELFKTMVRFGDVGLDLDFSSFDASLSPFMIREAG-RILSEMSGTPSHFGEA 
YIDYLNHSHHLYKNKTYCVKGGMPS~~SG~SIFNSMINNLIIRTLLLKTYKG---IDLDH 
YIDYLCNSHHLYRNKHYFVRGGMPSGCSGTSIFNSMINNIIIRTLMLKVYKG---IDLDQ 
LIQSICNTHHIFRDEIYVVEGGMPSGCSGTSIFNSMINNIIIRTLILDAYKG---IDLDK 
LIDRLCKSKHIFKNTYYEVEGGVPSGCSGT~IFNTMINNIIIRTLVLDAYKN---IDLDK 
YLESLAISTHAFEEKRFLITGGLPSGCAATSMLNTIMNNIII~GLYLTYKN---FEFDD 
ILKTLVNTEHAYENKRIIVEGGMPSGCSATSIINTlLNNIYVLYALRRHYEG---VELDT 
LINTIIYSKHLLYNCCYHVCGSMPSGSPCTALLNSIINNINLYYVFSKIFRKSPVFFGDA 
LINTIIYSKHLLYNCCYHWGSMPSGSPCTALLNSIVNNVNLYYVFSKIFRKSPVFFGDA 
0.0 
LKMIAYGDDVIA--SYPHEVD-ASLLAQS ----GKDYGLTMTPADKSA-IF-ETVTWEN 
FRMIAYGDDVIA--SYPWPID-ASLLAEA ----GKGYGLIMTPADKGE-CF-NEVTWTN 
LKILAYGDDLIV--SYPYELD-PDVLATL ----GKNYGLTITPPDKSE-TF-TKMTWEN 
LKIIAYGDDVIF--SYIHELD-MEAIAIE ----GVKYGLTITPADKSN-TF-VKLDYSN 
VKVLSYGDDLLV--ATNYQLD-FDKVRAS-----LAKTGYKITPANTTS-TFPLNSTLED 
YIMISYGDDIVV--ASDYDLD-FEALKPH---- FKSLGQTITPADKSDKGFVLGQSLTD 
LRILCYGDDVLIVFSRDVQIDNLDLIGQKIVDEFKKLGMTATSADKN---VPQLKPVSE 
LKILCYGDDVLIVFSRNVQIDNLESIGQKIVDEFGKLGMTATSADKS---VPKLKPISE 
VTFLKRFFRADEKYPFLIHFVMPMKEHESI-RW 
VTFLKRYFRADEQYPFLVHPAMPMKDHESI-RW 
LTFLKRYFKRDQQTPFLVHPVMPMKDHESI-RW 
VTFLKRGFKQDEKYNFLIHPTFPEDEFESI-RW 
VVFT.KRKFKKE--GP-LYRPVMNREA-EAMLSY 
VTFLKRHFHMD-YGTGFYKPVMASKT-EAILSF 
LTFLKRSFNLVE ---DRIRPAISEKTIWSLIAW 
LTFLKRSFNLVE ---DRIRPAISEKTIWSLVAW 
Fig.2. Amino acid alignment of fragment from the 3D (RNA polymerase) region for simian HAV with other picornaviruses (conserved 
amino acids forming the putative active site of the enzyme are indicated th the large dots). 
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do not alter the putative active site of the enzyme. 
Conserved amino acids presumably responsible for 
enzymatic function of the 3D protein remain un- 
changed in the simian HAV. 
4. DISCUSSION 
The HAVs of simian origin have not yet been in- 
tensively studied. In the only previous paper on the 
same subject, genomic heterogeneity among 
human and non-human HAV strains has been 
demonstrated by the failure to hybridize simian 
HAV RNAs with cDNA probes derived from the 
human HAV genome [ 191. The differences seem to 
be located in the region coding for virus structural 
proteins (VP1 and VP2). 
The significance of variations in the region 
coding for non-structural proteins remains ob- 
scure. It is of interest that among the human HAV 
strains compared to date, differences in the 3D 
(RNA polymerase) region do not exceed 7-9 
substitutions in amino acid sequences (over 98% 
identity) [6-81. In contrast, the simian HAV ex- 
amined here exhibits significant differences from 
human HAV in the amino acid composition of the 
3D region: the number of substitutions was found 
to be 44 in the fragments representing approx. 95% 
of the length of this region, equalling 90% amino 
acid identity. A comparison of human HAV with 
poliovirus type 1 Mahoney strain showed the 
amino acid identity of the 3D region to be 29% [9]. 
Despite the poor degree of homology in the regions 
coding for structural [19] as well as non-structural 
(this work) proteins, human and simian HAVs re- 
tain close antigenic relatedness and presumably 
similar enzymatic (RNA polymerase) function. 
This observation prompts us to investigate the 
evolutionary relationship among HAVs originating 
from different hosts in the order of Primates. 
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